• Immunotherapy Changing How the World Treats Cancer

    When it comes to cancer treatment, we make it personal. With immunotherapy, we reprogram your immune cells, so they can do what they do best: Destroy infection and illness, like cancer. Our CAR T-cell therapy was the very first immunotherapy in the world to be FDA-approved, and this is just the start. 

    Carl June and Robert Vonderheide working together in a laboratory
  • Novel Therapies Proton Therapy

    At Penn, we have the largest proton therapy center of its kind. Proton therapy is a type of very precise radiation treatment. During the treatment, a proton beam conforms to the shape of a tumor, while sparing healthy tissues and organs.

    treatment types proton therapy
  • National Recognition "Exceptional" Rating by National Cancer Institute

    The NCI rating signifies the renewal of our status as a “comprehensive” center - demonstrating an added depth and breadth of multidisciplinary laboratory, clinical and population-based research, as well as substantial trans-disciplinary research.


Why Penn?

Up to the Minute Advances in Research

What Sets Penn Medicine Clinical Trials Apart?

Abramson Cancer Center has been a national leader in developing and conducting clinical trials for the prevention, diagnosis and treatment of cancer.

CAR-T Cell Therapy: Using Healthy Cells to Fight Cancer

Learn about the process behind Penn’s CAR-T cell therapy, the first-ever cancer treatment that genetically alters a patient’s own immune cells to target and destroy cancer cells.

Translating Research into Practice

Translational Centers of Excellence aim to find solutions to the most pressing issues confronting cancer patients.

TumorGlow® Technology

Penn's Center for Precision Surgery is testing the impact of an investigational dye designed to make tumors “glow" during surgery, so we can more easily detect and remove cancerous tumors.